Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Adherence for VTE Prophylaxis After Cancer Surgery
NCT04479579Phase 4Completed
- Sponsor
- McMaster University
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by McMaster University. Started Feb 2021; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04479579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479579.